Across larger cohorts, 60 to 70% of VP patients exhibit an abnormal striatal DAT uptake (56, 58, 63), but reductions are generally milder and more symmetric than in PD (53, 56, 58, 66, 70, 71). This evidence concerns the gene SLC6A3 and Parkinson disease.